That is, C1q (fold change 4.2; p < 0.001), C1s (; fold change 4.0; p < 0.001) and C4a (fold change 2.1; p < 0.001) were significantly up-regulated in material from patients with glioblastoma as compared to non-tumor controls. The gene discussed is C1S; the disease is glioblastoma.